Compliance and adverse event withdrawal: Their impact on the West of Scotland Coronary Prevention Study

European Heart Journal

Volumn 18, Issue 11, 1997, Pages 1718-1724

  Shepherd, J ^a   Cobbe, S M ^a   Lorimer, A R ^a   McKillop, J H ^a   Ford, I ^a   Packard, C J ^a   Macfarlane, P W ^a   Isles, C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

All cause mortality; Compliance; Coronary heart disease; On treatment analysis; Pravastatin; Primary prevention; Withdrawals

Indexed keywords

PRAVASTATIN;

ADULT; ARTICLE; BLOOD TOXICITY; CARDIOTOXICITY; CLINICAL TRIAL; COHORT ANALYSIS; CORONARY RISK; COST EFFECTIVENESS ANALYSIS; DRUG WITHDRAWAL; EYE TOXICITY; FATIGUE; GASTROINTESTINAL SYMPTOM; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNOTOXICITY; ISCHEMIC HEART DISEASE; LABYRINTHITIS; LETHARGY; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALAISE; MALE; MENIERE DISEASE; MORTALITY; NEUROTOXICITY; PATIENT COMPLIANCE; PRIMARY PREVENTION; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; SKIN TOXICITY; TINNITUS; UNITED KINGDOM;

EID: 0030668569     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.eurheartj.a015165     Document Type: Article

References (17)